| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,101 |
9,695 |
$1.44M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,424 |
3,066 |
$1.05M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,143 |
2,178 |
$223K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,997 |
3,865 |
$172K |
| 87428 |
|
2,812 |
2,752 |
$153K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
175 |
139 |
$111K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
698 |
625 |
$63K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,547 |
1,142 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
354 |
334 |
$25K |
| 71045 |
Radiologic examination, chest; single view |
676 |
618 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
624 |
608 |
$16K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
193 |
183 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,941 |
1,739 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,645 |
2,321 |
$13K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
13 |
12 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,200 |
685 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
25 |
25 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
76 |
75 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
939 |
849 |
$4K |
| 87070 |
|
279 |
273 |
$4K |
| 94760 |
|
61 |
41 |
$4K |
| 81001 |
|
1,300 |
1,217 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
76 |
75 |
$2K |
| 84484 |
|
387 |
287 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
358 |
323 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
32 |
26 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
117 |
114 |
$2K |
| 83880 |
|
58 |
56 |
$1K |
| 80061 |
Lipid panel |
258 |
252 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
116 |
113 |
$989.86 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
170 |
163 |
$729.16 |
| 90461 |
|
194 |
62 |
$728.73 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
127 |
122 |
$411.07 |
| 90686 |
|
281 |
279 |
$349.37 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
108 |
103 |
$340.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
343 |
304 |
$292.92 |
| 87807 |
|
13 |
12 |
$255.43 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
129 |
103 |
$78.73 |
| 87186 |
|
24 |
24 |
$50.13 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
13 |
13 |
$45.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$38.60 |
| 36415 |
Collection of venous blood by venipuncture |
1,398 |
1,246 |
$17.67 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
236 |
222 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
298 |
274 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |
| 90662 |
|
14 |
14 |
$0.00 |
| 82962 |
|
335 |
173 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25 |
24 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
13 |
12 |
$0.00 |
| 90651 |
|
13 |
13 |
$0.00 |